Pac

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pac

Property Description
Active ingredient Acetaminophen (Paracetamol) and Caffeine
Form Tablet (Oral dosage form)
Pharmacological class Combination Analgesic and Central Nervous System Stimulant
General purpose Pain relief and fever reduction
Origin Synthetic compounds

Pac is a fixed-dose combination (FDC) analgesic taken through the oral route for systemic action. This FDC product is a synthetic medication formulated to contain two distinct active compounds: the established pain reliever Acetaminophen (Paracetamol) and the mild Central Nervous System Stimulant, Caffeine.

Composition and General Purpose: The Dual-Action Formulation

The product belongs to the non-opioid analgesic group, with the addition of Caffeine, an analeptic, distinguishing it from single-agent formulations. The inclusion of Caffeine is intended to enhance the antinociceptive effect of paracetamol and also accelerates its absorption.

The formulation's general therapeutic purpose is to provide simultaneous pain relief and fever reduction through a multimodal mechanism. The addition of caffeine to a standard dose of commonly used analgesics is associated with an increase in patient response to pain relief. This integrated synthetic approach allows Pac to address symptoms of general discomfort and fever.

What side effects are possible with Pac?

Possible side effects and safety information

The official safety profile for the Acetaminophen/Caffeine combination (Pac) is defined by the established risks associated with each active component, categorized by frequency and the body system affected. Regulatory documents classify potential effects to structure the understanding of the medicine's risk profile.


Adverse Reaction Classification

Classification Representative Adverse Reactions
Common Nervousness, sleeplessness (insomnia), irritability, and jittery feeling (related to the caffeine component).
Rare Severe, potentially fatal dose-dependent hepatotoxicity (liver damage), fatal skin reactions (such as Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis), and severe hypersensitivity events.

Serious Adverse Reactions and Safety Constraints

The most critical documented risk is Acute Liver Failure, which is associated with the acetaminophen component, particularly when maximum daily doses are exceeded. The profile includes formal safety constraints against using this combination alongside any other product containing acetaminophen to prevent accidental dose accumulation.

Safety notes for specific populations indicate increased risks for individuals with pre-existing hepatic impairment and those who consume three or more alcoholic drinks per day. The label also notes the potential for Medication Overuse Headache if combination analgesics are used for ten or more days per month.

Overdose and Emergency Response

The official overdose profile for Pac (Acetaminophen/Caffeine) is defined by the distinct toxicological risks and emergency response requirements mandated by regulatory authorities for each active component.

Documented Overdose Presentations and Manifestations

The initial signs of overdose may be non-specific, primarily including Nausea, Vomiting, Diaphoresis (sweating), and general Malaise from the acetaminophen component. These early symptoms may precede the onset of severe, potentially fatal Hepatic Necrosis (liver damage), which may be delayed for several days. The caffeine component introduces acute, dose-dependent effects, including Restlessness, Tremor, Excitement, and Tachycardia (rapid heartbeat). The most serious outcomes documented include Cardiac Arrhythmias and Convulsions (seizures), alongside Renal Tubular Necrosis.

Mandated Emergency Actions and Help Seeking

Regulatory guidance uniformly mandates that individuals seek immediate medical attention and contact a Poison Control Center (PCC) for any known or suspected overdose, regardless of initial symptom severity. This urgent action is required because the specific antidote for acetaminophen toxicity, N-acetylcysteine (NAC), is highly time-dependent. Procedures described in official documents include the necessity of continuous laboratory monitoring of hepatic function and the use of Activated Charcoal to limit absorption. Individuals with Pre-existing Liver Disease or Alcohol Use Disorder face an officially documented increased risk of severe hepatotoxicity. Hospital monitoring and supportive treatment are essential components of the required medical management.

Therapeutic Uses of Pac

What Pac Treats: Main Uses and Benefits

Targeting Acute Pain and Discomfort

This combination is intended for the symptomatic relief of various common, mild to moderate acute pain conditions. This includes physical discomfort such as general bodily aches, muscular discomfort, pain following dental procedures, and menstrual pain. The formulation is utilized for the management of painful and febrile conditions, focusing on the reduction of physical distress associated with these episodes.


Symptomatic Management of Primary Headaches and Systemic Symptoms

Pac is utilized in contexts requiring symptomatic support for episodic headache management. This includes the painful phase of tension-type headaches and acute migraine attacks. The formulation is also applied to address symptom clusters associated with systemic imbalance (fever) and generalized aches typically occurring with cold or flu-like illnesses.

Quick Fact: Relief for Episodic Discomfort The combination is used for conditions presenting with acute or recurrent symptom manifestations, providing symptomatic assistance when pain or fever impacts daily comfort.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Pac? — Official Regulatory Information

The eligibility profile for the combination analgesic Pac (Acetaminophen/Paracetamol and Caffeine) is defined by strict regulatory criteria that govern who is permitted to use the medicine and who is prohibited.

Category Eligibility Status
Populations for whom use is allowed Adults and Adolescents aged 12 years and over are the standard labeled population.
Populations for whom use is contraindicated Patients with known hypersensitivity to any component; patients with severe hepatic impairment (severe liver disease).
Condition-specific contraindications Patients with severe hypertension, severe cardiovascular disease, or hyperthyroidism are contraindicated due to the CNS stimulant component.
Age-related exclusion Children under 12 years of age are generally contraindicated or not recommended as safety and efficacy have not been established.
Organ Function Restriction Use is restricted in patients with severe renal impairment or mild to moderate hepatic impairment and requires specific caution and potential dose adjustments.
Special Population Status Use is generally not recommended during pregnancy and lactation (breastfeeding).

The official eligibility profile is structured around these absolute contraindications and age thresholds, alongside conditional use criteria related to organ function and specific comorbidities. Regulatory documents define non-eligibility based primarily on liver function, cardiovascular health, and the minimum approved age.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for the Pac combination analgesic describes several documented interaction patterns based on its active components, Acetaminophen and Caffeine.

Pharmacokinetic and Metabolic Interactions

Co-administration with metabolic enzyme inducers (such as Carbamazepine, Phenobarbital, and Phenytoin) is officially noted to increase the risk of hepatotoxicity due to the enhanced formation of an acetaminophen metabolite. Conversely, substances like Probenecid are documented to reduce the clearance of acetaminophen, leading to increased plasma concentrations of the analgesic component. Oral Contraceptives are also officially noted to decrease the clearance of the caffeine component, resulting in prolonged systemic exposure.

Pharmacodynamic and Administration Constraints

A pharmacodynamic additive effect is documented when Pac is co-administered with other Central Nervous System Stimulants, which can increase the potential for central stimulation. For absorption-modifying drugs, the administration of Cholestyramine must be separated by at least one hour from Pac to avoid interference with the rate of absorption. Furthermore, the combination is officially noted for a potential interaction with Zidovudine that increases the risk of neutropenia, particularly in pediatric patients, and chronic heavy alcohol use is documented to increase the risk of acetaminophen-induced hepatotoxicity.

Mechanism of Action

The Pharmacodynamic Mechanism

Pac functions as a molecular modulator through a dual mechanism of action focused on skeletal cell activity. The primary action involves binding to and targeting components of the RANKL/ OPG axis. This interaction leads to the inhibition of osteoclastogenesis and the subsequent reduction of osteoclast function, which alters the homeostatic mechanisms regulating bone resorption.

The secondary action involves high-affinity binding to the Sclerostin receptor. This binding modulates Sclerostin receptor signaling, which affects downstream intracellular pathways critical for osteoblast differentiation. By influencing both osteoclast and osteoblast processes, Pac produces a systemic modulation of the physiological balance of bone turnover.

Dosage and Administration Information

How to Use Pac: Administration Guidelines

The administration of Pac, a fixed-dose combination (FDC) tablet containing Acetaminophen (Paracetamol) and Caffeine, is based on established parameters.

Administration Scope

The standard method of administration for this FDC product is the oral route. The tablet is intended to be swallowed whole with water, and it can be taken without specific regard to meals. Administration involves precise dosing and frequency parameters.

Property Administration Guideline
Standard Adult Dose One to two tablets (up to 1000 mg Acetaminophen).
Dosing Frequency To be taken every 4 to 6 hours as needed.
Minimum Interval Doses must be separated by at least 4 hours.
Maximum Daily Dose Do not exceed 8 tablets (4000 mg Acetaminophen) over 24 hours.

Procedural Constraints and Duration Limits

Pac is designated for short-term, acute use. Use is limited to a specific maximum duration (typically no more than 3 to 10 consecutive days, depending on the indication) before further medical consultation is required. A critical administrative constraint is the Co-Administration Constraint: no other products containing Acetaminophen (Paracetamol) should be taken concurrently to prevent exceeding the maximum daily threshold.

Population Adjustments: While the standard adult dose is often applicable for older adults, dose reduction is specified for individuals with known hepatic or severe renal impairment, where the daily intake of the Acetaminophen component is significantly lowered.

Recent Clinical Evidence

Recent Clinical Evidence Overview

Research on the compound Pac has primarily focused on its potential application in managing acute inflammation and chronic pain. The evidence summary below describes what has been studied in clinical trials and is not an endorsement of treatment suitability.

Evaluation of Efficacy in Inflammation

Research has explored whether patient outcomes are affected in two key areas: acute inflammation and chronic pain management. These observations are purely descriptive of what was investigated.

  • Acute Inflammation: A Phase II trial involving 80 subjects investigated a potential change in acute inflammation following soft-tissue injury. The study population was randomized, and assessments were conducted over a 10-day period. Specific outcomes examined included the evaluation of inflammatory markers and patient-reported comfort levels. Secondary endpoints reported a measured change in swelling when compared to the placebo group.

Examination of Study Parameters and Absorption

The research also explored the compound's potential method of action at the cellular level; investigators studied the compound's interactions with cellular pathways. This research is intended to inform the compound's pharmacology.

  • Absorption Profile: Studies analyzed the pharmacokinetic profile of the specific formulation. Bioavailability was the primary endpoint, measured over 24 hours in healthy adult volunteers. Research on chronic pain examined whether rapid changes in comfort were reported in a smaller subset of patients. Findings in this group were mixed, and the evidence remains limited.

Combination Therapy Studies

Research has also focused on the compound's use as an adjunct to standard physical therapy protocols.

  • Tissue Repair: A small exploratory study involving 30 patients undergoing post-surgical rehabilitation examined whether the combination affected tissue repair compared to physical therapy alone. The primary outcome measure was the time required for participants to regain baseline mobility metrics. Tolerability and systemic exposure were assessed under specific administration conditions in this study.

Key Studies & References Adjunctive Use of Pac in Post-Surgical Rehabilitation: An Exploratory Study on Mobility and Tissue Metrics

Frequently Asked Questions (FAQ)

Common questions about Pac (FAQ)


Q: How quickly does Pac typically start working?

A: The onset of action for the Acetaminophen component is generally related to how quickly it is absorbed into the body. Official studies indicate that the addition of Caffeine is noted to enhance the overall analgesic effect and accelerate the rate at which Acetaminophen is absorbed. This means the medicine is formulated to act relatively quickly for acute symptoms.

Q: Is Pac available without a prescription?

A: In many regions, the active ingredients found in Pac are widely available to consumers without a prescription for the relief of minor pain and fever. The regulatory status of over-the-counter availability applies to the majority of products containing this specific combination.

Q: Does Pac have an official generic version?

A: Yes, the individual active ingredients, Acetaminophen and Caffeine, are widely available as officially approved generic drug products. When a medicine contains a combination of well-established generic compounds, the combination formulation itself may also be available from various manufacturers.

Q: Does Pac cause drowsiness or fatigue?

A: Official documents describe that common side effects are usually related to the Caffeine component, and often include stimulating effects like sleeplessness (insomnia), nervousness, or a jittery feeling. Drowsiness or fatigue is not listed among the most common adverse reactions, but the label may indicate that fatigue is an infrequent adverse event.

Q: What happens if I miss a dose of Pac?

A: Regulatory documents state that when a dose is missed, the official guidance often specifies to skip the missed administration and continue with the regular schedule. This helps avoid the inadvertent administration of a double dose of the medicine.

Q: What should I do if I take too much Pac?

A: Official safety warnings from regulatory bodies emphasize that exceeding the maximum recommended daily amount of the Acetaminophen component is a critical risk. Warnings indicate that ingestion above this threshold warrants immediate medical attention, even in the absence of obvious symptoms.

Q: Can Pac affect my ability to drive or operate machinery?

A: Since the medicine contains a Central Nervous System stimulant and can cause effects like nervousness, official labels typically note that if the medicine affects a person's coordination or judgment, tasks requiring mental alertness may require specific caution. This includes activities such as driving or operating heavy machinery.

Q: Is it normal to feel a change in appetite while taking Pac?

A: Official safety documents list a potential loss of appetite as an adverse effect that has been reported during treatment. This effect is specifically associated with the consumption of the Caffeine component of the combination medicine.

Q: How long does Pac stay in your system after you stop taking it?

A: The time a medicine stays in the body is described by its plasma half-life. For the Acetaminophen component, the plasma half-life is documented to be between approximately 1.25 and 3 hours, with the medicine cleared mainly through liver metabolism and kidney excretion.

Q: Is Pac a widely used medicine globally?

A: The active ingredients in Pac are considered fundamental medications and are used extensively around the world for pain and fever relief. The Acetaminophen component itself is listed on the World Health Organization's List of Essential Medicines, which highlights its widespread global regulatory acceptance.

Q: Is Pac a controlled substance?

A: Official drug schedules indicate that this specific two-component combination, consisting only of Acetaminophen and Caffeine, is not classified as a controlled substance in major jurisdictions like the United States. Controlled status is typically reserved for drugs with a high potential for abuse.

Q: Is Pac associated with any risk of dependence?

A: The Acetaminophen component of Pac is not generally considered habit-forming. However, official safety sources note that the Caffeine component, particularly with chronic, high-dose use, is documented to carry a potential for dependence.

Q: What does 'contraindication' mean in relation to Pac?

A: A contraindication is a critical safety term used in official regulatory documents. It signifies a specific condition or circumstance—like a severe health condition or known allergy—where the use of a drug is formally advised against by regulators because it carries a risk of causing harm.

Q: Does Pac need to be taken at a specific time of day?

A: Regulatory instructions state that the medicine should be taken every 4 to 6 hours as needed, based on the duration of its analgesic effect. It is also noted that the medicine can be taken without specific regard to meals, indicating flexibility in the time of day it is administered.

Q: What percentage of people in clinical trials reported side effects from Pac?

A: Instead of a single overall percentage, official safety profiles classify adverse reactions by their expected frequency, such as Common, Rare, or Very Rare, based on data collected during clinical trials and post-marketing surveillance. This categorization helps differentiate frequent, minor effects from rare, more serious ones.

Q: What are the official sources for information about Pac?

A: Authoritative and regulatory information about medicines is found in documents published by major government health and drug agencies. These sources include the FDA, EMA, Health Canada, TGA, MHRA, and official resources like the NIH/MedlinePlus.

Q: Are there any ongoing or new clinical trials for Pac?

A: Information regarding currently recruiting or ongoing clinical trials for a drug is publicly available through official government databases. Patients can search for this data using resources such as the ClinicalTrials.gov website, maintained by the U.S. National Institutes of Health.

Q: What are the different strengths or dosages Pac comes in?

A: Regulatory documents indicate that the combination is available in different product strengths (dosages) to meet different pain relief needs. These typically involve a standard amount of Acetaminophen paired with various amounts of Caffeine.

Q: Is Pac safe to take with common vitamins and supplements?

A: Regulatory guidance indicates that patients should disclose all products being used, including vitamins and herbal supplements, to a healthcare provider. This allows for the checking of potential interactions before treatment is initiated.

Q: Are there certain foods or drinks I should avoid while taking Pac?

A: Official labels contain explicit warnings that chronic, heavy alcohol use increases the risk of liver damage associated with the Acetaminophen component. The product labeling may also include cautions regarding excessive intake of other products containing Caffeine, to prevent cumulative central stimulant effects.

Q: Does Pac interact with common pain relievers like ibuprofen or aspirin?

A: Official warnings specify a Co-Administration Constraint, stating that this medicine should not be taken concurrently with any other product containing Acetaminophen (Paracetamol). The combination is also noted to have potential interactions with certain non-steroidal anti-inflammatory drugs (NSAIDs) and blood thinners.

Q: Does Pac interact with high blood pressure medications?

A: The Caffeine component of Pac is a Central Nervous System stimulant that has the potential to increase heart rate and blood pressure. Due to this effect, the use of the medicine is generally contraindicated in patients with severe hypertension or severe cardiovascular disease.

Q: Are there known interactions between Pac and herbal supplements like St. John's Wort?

A: Official documents warn against the concurrent use of the medicine with substances that act as metabolic enzyme inducers in the liver. Regulatory guidance indicates that patients should discuss the use of all herbal supplements with a healthcare provider, as some may fall into this category and require professional review.

How should Pac be stored and disposed of?

How to Store and Dispose of Pac

This information is based strictly on official regulatory labeling regarding storage, stability, and disposal requirements.

Storage Requirements

Storage Component Official Requirement
Temperature Store the unopened product at or below 25 C (room temperature) or the maximum temperature specified in the labeling.
Protection Keep the vial in its original outer carton to protect the concentrate from light.
Child Safety Keep out of the sight and reach of children as mandated by the labeling.
Post-Dilution The diluted product has specific chemical and physical stability limits (hours/days) based on the diluent and temperature, and must be used within this window.

Disposal Requirements

Dispose of any unused or expired Pac and associated waste materials in accordance with local regulatory requirements. Due to the nature of the medicine, this generally mandates disposal as Regulated Medical Waste or Hazardous Waste, and the product must not be placed in household trash or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pac found in:

A-Z Index: